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Abstract
Background: Community engagement (CE) is a well-established practical and scholarly field, recognised as core to
the science and ethics of health research, for which researchers and practitioners have increasingly asked questions
about desired standards and evaluation. In infectious disease outbreak contexts, questions may be more complex.
However, it is unclear what body of knowledge has been developed for CE specifically as it applies to emerging
infectious diseases. This scoping review seeks to describe (1) How CE has been conceptualised and understood; and
(2) What conclusions have research teams reached on the effectiveness of CE in these settings, including challenges
and facilitators.
Methods: We used a scoping review framework by Arksey and O’Malley (Int J Soc Res Methodol 8:19–32, 2005) to
structure our review. We conducted a brainstorming session and initial trial search to inform the protocol, search
terms, and strategy. Three researchers discussed, developed and applied agreed screening tools and selection
criteria to the final search results. Five researchers used the screening tools to screen abstracts and full text for
inclusion by consensus. Additional publications were sought from references of retrieved publications and an
expert call for literature. We analysed and reported emerging themes qualitatively.
Results: We included 59 papers from a total of 722 articles derived from our trial and final literature searches, as
well as a process of “citation chasing” and an expert call for grey literature. The core material related exclusively to
health research trials during the 2014–2016 West Africa Ebola outbreak. We synthesized reports on components of
effectiveness of CE to identify and propose three themes as essential elements of effective CE.
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Conclusions: While there is a large volume of literature documenting CE activities in infectious disease research
settings generally, there are few accounts of effectiveness dimensions of CE. Our review proposes three themes to
facilitate the effectiveness of CE initiatives as essential elements of CE activities in infectious diseases studies: (1)
Communication towards building collaborative relationships; (2) Producing contextual knowledge; and (3) Learning
lessons over time. As there were relatively few in-depth accounts of CE from our literature review, documentation
and accounts of CE used in health research should be prioritised.
Keywords: Community engagement, Effectiveness, Health research, Epidemics, Outbreaks, Infectious disease, Sub-
Saharan Africa
Background
CE has become an ethical requirement for research in-
volving human participants [52]. Dickert and Sugarman
[19] have identified four ethical goals of CE: enhancing
protection, enhancing benefits, creating legitimacy, and
sharing responsibility. In the 2000s, there were signifi-
cant developments in CE in clinical trials in Sub-
Saharan Africa, especially human immunodeficiency
virus (HIV) trials. These changes were motivated by the
early closure of pre-exposure prophylaxis (PrEP) trials in
Cambodia and Cameroon following protests led by HIV
activists who argued trial participants were taking risks
but not receiving enough benefits [41]. In response, ac-
tivists called for a strengthened role of communities in
the development and the conduct of HIV trials and
pushed for a broader view of CE to promote community
empowerment and shared decision-making [50]. Follow-
ing these calls, there have been a number of successes in
promoting dialogue with communities, especially the
transformation from an activist-led movement that
‘pushed’ for inclusion, to a researcher-led effort, where
study staff worked to encourage participation and
‘pull’ communities into relationships with researchers
[38, 50]. Although there have been positive develop-
ments in CE, there are concerns that CE in clinical
trials does not always address the broader concerns
of participants, governments, activists, and researchers
themselves, especially political and economic issues
related to involving people from resource poor
communities [43].
With the growing number of clinical trials around emer-
ging diseases in the last five years, there have been further
calls for improved CE, especially in emergency situations.
The 2014–16 Ebola Virus Disease (EVD) outbreak in
West Africa led to the deaths of more than 11,000 people
in Sierra Leone, Liberia and Guinea [57]. Experiences
during the response to the epidemic revealed to a broader
community of scientists the dangers of ineffective CE,
especially mistrust between communities and authorities
[27]. In the wake of these experiences, a number of guide-
lines and reports were published for CE for clinical trials
for emerging diseases [15].
The Good Participatory Practice Guidelines for Trials of
Emerging (and Re-emerging) Pathogens (GPP-EP) [57] set
out recommendations for stakeholder engagement that
draw from an expert base of actors involved in the EVD
outbreak, and borrow from biomedical HIV intervention
‘good participatory practice’ trial guidelines (e.g. [53]). The
GPP-EP addresses key concepts in stakeholder engage-
ment rather than community engagement, defining stake-
holders, ethical issues, and the need for long-term,
sustained partnerships. In this document, using the term
‘stakeholder’ rather than ‘community’ in discussing
engagement as the focus implies a larger set of health re-
search actors. Here ‘synergy’ between research and re-
sponse is also seen as crucial to set out ethical principles
and ‘optimal practice’ through nine activities throughout
the research life-cycle [57]. The GPP-EP recommends
processes to develop research protocols, budget allocation
and time, and collaborative partnering for a “collective
shaping of relevant, scientifically rigorous, ethical research
that is in line with international standards, respects the
rights of the involved population, contributes to and does
not undermine the epidemic response, and leaves a sus-
taining legacy for the involved population” (ibid. p. 4). Ef-
fective engagement is both an intrinsic ethical imperative
and has instrumental value toward enhancing trial con-
duct and contributing to robust research outcomes. While
the window of opportunity for research during an out-
break is short, trial stakeholder identification and engage-
ment is crucial. The foundational GPP-EP principles
underpin partnerships with “respect, fairness, integrity,
transparency, accountability, and autonomy, while the
benchmarks include mutual understanding, complemen-
tarity, and efficiency” (ibid. p. 5).
In addition to the World Health Organization (WHO)
report, an ad hoc committee was formed at the National
Academies of Sciences, Engineering, and Medicine to
review and conduct an analysis of the clinical trials
conducted during the 2014–2016 EVD outbreak. Their
consensus report explores and analyses the scientific and
ethical issues related to clinical trial design, conduct, and
reporting. The report’s second chapter focuses on “Con-
ducting clinical research during an epidemic” [34]. The
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core recommendations include: i) begin CE early (recog-
nising contingency of health research and the public
health response); ii) ensure that CE is ‘meaningful’ (that
is, that experiences are comprehensively and transpar-
ently reported and utilised); and iii) maintain sustained
funding and investment to develop relationships in
inter-epidemic periods. The report recognises the key
role of social scientists or anthropologists in learning
about cultural, social, political and historical dynamics
that could affect CE and research and emphasises pro-
moting the voices of local experts, leaders and commu-
nity liaison staff. From a practical perspective, the
authors describe the need for communication to engage
multiple stakeholders in multiple ways, and ensure infor-
mation is accurately presented, including through
translations.
Although these documents provide good guidance on
CE, there has been no scoping review of the conduct of
CE in emerging disease treatment and prevention trials.
At this stage, an assessment of methods for measuring
the ‘effectiveness’ of CE would be useful to strengthen
and broaden these approaches. However, the existing di-
versity of definitions and methods for evaluating CE ac-
tivities may preclude such an effort [2]. For this reason,
we have focused this scoping literature review on the
practice of CE by aiming to answer two key questions:
(1) How has CE been conceptualised and understood?
(2) What conclusions have research teams reached on
the effectiveness of CE, including the challenges and fa-
cilitating factors described?
Methods
We used a scoping review methodological framework
provided by Arksey and O’Malley [4] to structure our re-
view focusing on papers that documented community
engagement in health research on infectious diseases.
The review stages included: literature search strategy,
trial literature search, literature searching, and reference
search from final search. We began with a brainstorming
session to define the search parameters, including key
terms, inclusion and exclusion criteria and appropriate
Boolean operators. As some concepts in our questions
were ambiguous or difficult to define, we compiled a
comprehensive list of search term synonyms.
We then conducted an initial trial search to test our
search strategy and make adjustments on one database,
Scopus. The trial search used two limits: peer-reviewed
papers published after 1990 in English, including all
types of research studies (e.g. randomised controlled tri-
als, cohort studies, surveys and qualitative studies). After
our trial search we devised our protocol document and
registered it on Prospero (CRD42018112501). The 'final'
search was conducted across multiple databases.
We also searched through references of publications re-
trieved from our final search for additional publications.
This was a process of ‘backward’ and ‘forward’ citation
chasing of included articles [9] for additional follow up
references, where we identified linked studies by checking
bibliographies of included reviews and conducting citation
searches of our core papers. Three researchers (MV, SV,
and VM) were responsible for discussing and applying the
agreed screening tools and selection criteria to the final
search results. Five researchers (MV, SV, MM, VM and
SK) used the screening tools to screen abstracts and then
full text of selected articles for inclusion by consensus. Fi-
nally, we analysed and reported on the emergent themes
qualitatively.
An iterative process throughout each of the stages was
to clarify key concepts – identifying the key concepts,
debating their suitability to the context of health re-
search for infectious disease outbreaks in Sub-Saharan
Africa and producing a final list with related definitions.
We concentrated on the accounts of CE in six clinical
trials for which a substantial account of these activities is
given. Our final list is outlined in detail in the next
section.
Key concepts
In this review, ‘health research’ is taken to include all
health-related biomedical research. ‘Emerging (and re-
emerging) infectious disease outbreaks’ are those for
which there are few or no countermeasures to control
the transmission [56]. These outbreaks may also be re-
ferred to as epidemics if they spread across geographic
areas.
CE – ‘Community engagement’ – is a more ambiguous
term that encompasses a number of assumptions. A cen-
tral assumption in the reference to the ‘community’ is
that there are uniform communities and that these are
readily identifiable. Marsh et al. [38] acknowledge that
there are challenges such as defining ‘community’ and
addressing power differentials between researchers and
communities. As Wilkinson et al. [58] describe, ‘commu-
nity’ can also be a socio-political construct underpinned
by complex hierarchies and politics. The form of ‘com-
munity’ often differs across different types of health re-
search. For example, in treatment trials, participants are
recruited from an (often narrow) patient base, while in
vaccine trials participants may come from a broader
community of residents in a given geographic area.
There is also a lack of clarity between CE being an eth-
ical requirement with intrinsic value (mutual respect)
and practical requirement with instrumental value
(making health research feasible, acceptable, and maximising
benefits).
We refer to ‘engagement’ to include the time in antici-
pation of (before), during and after outbreaks (including
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future considerations) and across all forms of ‘engage-
ment’ or interaction. At the same time, we recognise
that ‘engagement’ is also a contested term and encom-
passes many activities with varying goals [9]. Sherry
Arnstein’s ‘Ladder of participation’ [5] is a popular rep-
resentation of the different levels of citizen involvement
from a situation of manipulation of citizens through cat-
egories of non-participation, to tokenism, to citizen
power, towards an open society of cooperation. The
form of engagement is often contingent on research
methods, though this is rarely explicit [37]. A highly vis-
ible, large-scale clinical trial may necessitate more robust
CE that puts at least some community members or trial
participants in decision making roles alongside re-
searchers. This type of engagement might be said to
democratise a research endeavour that might otherwise
risk being coercive or invasive. This legitimisation of re-
search institutions and practices is no less important
during epidemics, but it is likely to be more challenging
operationally for two main reasons. First, many institu-
tions’ relationships and practices are more fluid during
outbreaks, and therefore less predictable and more diffi-
cult to operate in. Second, any CE for research in out-
breaks is likely to be conducted alongside engagement
for the public health response.
Good practice in CE that achieves its aims is often de-
scribed in terms of ‘effectiveness’, though there are other
terms used (e.g. strength, quality, and impact) [17]. To
assess whether CE has been effective, the goals of en-
gagement need to be clear. In practice, CE activities can
have multiple aims that are sometimes conflicting, and
approaches to measuring achievement of these will be
similarly complex [42]. Given the contestations around
aims of CE and what constitutes good practice, we em-
ploy the ‘broad tent’ World Health Organization (WHO)
definition: “a process of developing relationships that en-
able stakeholders to work together to address health-
related issues and promote well-being to achieve positive
health impact and outcomes” ([59], p. 12).
Critical appraisal, coding and synthesis under themes
We used three guidelines for quality appraisal. These
guidelines were the ‘Critical Appraisal Skills
Programme’ (CASP) systematic review checklist [16],
the ‘Confidence in the Evidence from Reviews of
Qualitative research’ (CERqual) approach [36] to
determine robustness of results and the Authority,
Accuracy, Coverage, Objectivity, Date, Significance
(AACODS) checklist for critical evaluation of the grey
literature [35].
We draw on our findings to offer an analysis of major
elements of CE that are central to ‘effectiveness’ or good
practice in research through the development of three
core themes. We arrived at the themes during the analysis
phase, during which we sorted all the sources into cat-
egories beginning with disciplinary approaches and gen-
eral topic areas to be refined and reordered into themes
based on the objectives and outcomes of CE. During this
iterative process, we discussed the contents of each paper,
condensing what we had assessed and through these dis-
cussions derived themes, which were continually refined.
See Additional file 1 for the underlying conceptual frame-
work of the three core themes for effective CE.
Results
The total number of papers identified through database
searching was 460. In addition, the trial search returned
203 papers, which were screened for relevance based on
abstracts and titles (there were no duplicates as this search
was only run on one database). We found 17 articles rele-
vant to our question. After examining the overall rele-
vance of our trial search results and consulting a librarian
and experts in this field, we adapted search terms slightly
before moving onto the final search. However, 14 'missing'
articles from the initial trial search, which we had deemed
as relevant to our questions based on their title or abstract
but which did not appear in the final search due to the
changes in search terms, were included (the remaining
three articles that we had deemed relevant did appear in
the new search and thus were not included as these would
have been duplicates). The total number after duplicate
articles were removed was 470.
We screened these 470 titles and abstracts and excluded
412, leading us to a total of 58 articles for full text screen-
ing. Five people were involved in the full text screening of
58 articles, at which point a further 12 articles were ex-
cluded. In total the articles excluded on title and abstract
screening were 412. The full text screening was conducted
using a standardised screening template with the character-
istics outlined above, for which we also noted whether the
paper was included and any follow-up references. From the
full text screening, we generated a list of 50 follow-up refer-
ences, through ‘citation chasing’. We also made a call for
literature at the African coaLition for Epidemic Research,
Response and Training (ALERRT) consortium annual gen-
eral meeting held in March 2019 in Dakar, Senegal, based
largely on recommendations received by collaborators from
the consortium as well as pieces encountered during
searching and screening. This resulted in 9 pieces of grey
literature being collected from the recommendations of
experts.
Of this additional literature (grey and follow up refer-
ences) a total of 46 articles were excluded. The main reason
for excluding grey literature and citation chasing sources
was the content not being substantive enough. MV, SV and
VM met regularly to discuss screening choices and
approaches to synthesis and analysis. At the final stage a
total of 59 articles were included for analysis in the review.
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Accounts of CE in the literature
In the following section, we describe the CE activities
undertaken in six clinical trials, what was described as
‘working’ or not, why, and any lessons suggested. We then
describe the scope covered by a wider relevant litera-
ture on CE, including research accounts that refer-
ence CE activities and commentaries and analyses of
what constitutes good practice for CE. Drawing on
our findings, we offer an analysis of major elements
of CE that are central to ‘effectiveness’ or good prac-
tice in research. We then go on to present three
themes that summarise the conceptualisation and un-
derstandings of CE and the conclusions research
teams reached on the effectiveness of CE in their
settings.
Our final search across the electronic databases EBSCO-
host, OVID, Proquest, Pubmed, Scopus and Web of Sci-
ence returned 460 results. (See Additional file 2. for full
search terms.) After deduplication using the reference soft-
ware Mendeley, this was reduced to 267. Two of the
authors (MV and SV, with oversight from VM) conducted
a title and abstract screening round, which left articles
marked as ‘yes’ (include), ‘flagged for interest’ or ‘unsure’.
There were also 14 non-duplicated references from our ini-
tial trial search that we had flagged as relevant but did not
come up in our main search due to changes in search
terms. These were added manually to our spreadsheet of
references for full text screening. We then extracted data
using the characteristics in Table 1 below.
The Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) diagram in Fig. 1 above out-
lines our methodological process (see Additional file 3
for PRISMA Checklist).
Empirical research (trials) with substantial CE accounts
Papers on CE activities for Ebola treatment and preven-
tion trials in Sierra Leone, Liberia and Guinea were the
most substantial accounts of CE. These were either vac-
cine trials (four), which mostly recruited healthy volun-
teers from a wide community base, or treatment trials
Fig. 1 PRISMA diagram
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(two), which recruited in-patients during their stay in
isolation facilities. The vaccine trials aimed to recruit
healthy volunteers and had the strongest focus on CE as
part of their recruitment strategy and associated need to
engage with a wide area of local residents.
Table 2 below summarises the set-up, aims, and mech-
anisms of the CE strategy and activities, as reported in
the literature linked to six trials conducted during the
West Africa Ebola outbreak between 2014 and 2016.1
The trials varied in nature, size, design and in the scope
of their reporting on CE aspects of their research. While
all of the trials described CE to some degree – usually in
relation to ethical principles such as those used in Good
Clinical Research Practice – they used a variety of justifi-
cations, approaches and priorities as described later in
this section. The difficulty in describing detail is that,
from our review, it seems that CE for clinical trials is ei-
ther (i) not generally written up as a research activity
(for example, to evaluate progress towards goals) but as
a process, or (ii) write-ups are not comprehensive, par-
ticularly where published papers are primarily reporting
on trial activities and outcomes. For our analysis, there-
fore, we have gathered what is relevant and available
from the literature.
Other literature on CE during outbreaks: commentaries on
and shorter references to CE
In addition to reports of CE embedded in trials con-
ducted during the 2014–16 EVD outbreak, across the
trial-related literature there is a strong recognition of
the importance of CE in facilitating the implementation
of health research. For example, Folayan et al. [30]
identify four critical stakeholders and associated tasks
that need to be implemented before clinical trials begin.
These are: (1) Global research coordinating body
(WHO); (2) Affected governments; (3) Ethics commit-
tees; and (4) Community Advisory Boards (CABs). The
associated tasks centred around data-sharing and
exploiting synergies, access and leverage of resources,
reviewing/monitoring for ethical integrity, and working
with ethics committees. Processes that clarified the
roles and expectations of implementing partners for
better CE included the use of Standard Operating Pro-
cedures (SOPs) [46]. The use of SOPs was to provide
national and district-level guidance, such as recruiting
and training CE practitioners and how to structure so-
cial mobilisation or CE leadership alongside the rest of
the response effort.
In this review, the value of CE is often framed in terms
of encouraging support for the trial and the language
used to describe this tends to be linked to promotion,
enhancement and sensitisation [33, 47]. For example, the
instrumental value of CE is recognised for overcoming
challenges to both the outbreak research and the public
health response, in addressing rumours and changing
core risk behaviours, such as those around ‘unsafe’ burial
practices [10] and in introducing new measures like con-
tact tracing and quarantine [45].
In addition, one published report summarises the vac-
cination campaigns that were a major part of health re-
search during the 2014–2016 EVD outbreak in West
Africa. The Wellcome Trust and Center for Infectious
Disease Research and Policy (CIDRAP) report “Recom-
mendations for Accelerating the Development of Ebola
Vaccines” [14] provides a review and analysis of the vari-
ous aspects of research and development for Ebola vac-
cines, to provide an expert framework in the “global
efforts to accelerate the availability of effective and safe
Ebola vaccines” (ibid. p. 1). The report mostly focused
on post-marketing Ebola vaccination campaigns, rather
than trials or other health research activities. Despite the
post-marketing framing, it still offers general CE recom-
mendations that can be applied to health research.
Consideration of early strategies for CE for vaccine de-
ployment is included as well as descriptions of previous
experiences where CE played an important role in the
successful rollout of vaccines.2 The treatment trials were
not reported on as a group in this Wellcome and
CIDRAP report. An example of the type of research con-
ducted included testing the effectiveness of giving EVD









Experience, success and lessons/learnings
Exiting
1One of these trials is still ongoing (the Ebovac Salone trial). The
literature included in this section represents the results of our search
and may not include very recently published articles even if related to
these trials. The dominance of the 2014–2016 West Africa EVD
outbreak is a striking characteristic of our overall search results,
particularly given that we made an effort to keep our search terms as
inclusive of all the major WHO blueprint diseases as possible. This
suggests that there are significant gaps in the literature regarding CE
for health research in other infectious disease outbreaks.
2Reversing resistance to polio vaccination in northern Nigeria, random
selection for clinical trials of Malaria vaccines in Burkina Faso by using
traditional games, and frequent, widespread and multi-layered commu-
nication strategies for the Meningitis Vaccine Project in Central Africa
(ibid. p. 40–41).
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survivor plasma to patients, where the CE activities in-
cluded outreach to EVD survivors to request plasma
donation.
All of these trials received ethical approval from the
relevant international and national stakeholders [3, 39],
so they have demonstrated an intention and plan to con-
duct research that complies with ethical principles in re-
lation to informed consent, favourable risk-benefit ratio,
social value, respect for persons and communities [22].
The diversity with which these principles are interpreted
Table 2 Trial name, intervention, targeted recruitment population, reported CE strategy, activities, and outcomes
Trial Name Intervention Targeted recruitment
population
Reported CE strategy Reported CE activities and outcomes















health workers or related
care workers across 5
districts in Sierra Leone.
Dedicated significant time and resources
for CE. This meant communication
beginning before trial launch (and
presentation to the full government/
media). Communication continued post-
enrolment to support ongoing recruit-
ment and participation.
Communication activities included a
24-hour hotline for questions.
Educational activities involved more than
175 sensitisation and information sessions
for potential participants, hospitals,


















Social mobilisation began prior to any
vaccination related activities taking place.
Consent was gained from the main ring
site where the vaccination took place,
around the index patient’s residence.
‘Social mobilisation experts’ to find cases
and contacts who they sought to
mobilise and gain consent for
participation. Community leaders and
representatives assisted in contacting
patients where applicable. The experts
explained the trial’s objectives and









Iterative CE approach strongly informed
by prior and ongoing qualitative research.
‘Research-driven community engagement’
seen as contributing to smooth
recruitment and reducing disruption due
to rumours and misinformation.
Dedicated social science team and
community liaison teams aimed to
understand intra-community power dy-
namics. Conclusion that local understand-
ings of fairness can inform the
recruitment strategy design and rumours
can be addressed through ‘active dia-
logue’ rather than on correcting misinfor-
mation. This emerging understanding was
used to support and adapt CE over the















proximal and distal to an
identified referral hospital in
Monrovia.
Social mobilisation strategy with four
pillars: advocacy, communications,
community engagement and monitoring
and evaluation.
Activities included: Reaching out to
community decision-makers, opinion
leaders and political leaders for support
and approval, targeted messaging, an-
swering FAQs, print and broadcast media
communication, distributing flyers, jingles
and songs on television and radio, text
message communications with telecom-
munication companies’ subscribers etc.










Any patient aged > 1 year
with lab confirmed EVD;
four rural Ebola treatment
centers (ETCs) in Guinea.
The trial organisers recognised the context
of fear and mistrust of international actors.
The main recruitment efforts were inside
the four ETCs involved in the study. A CAB
was set up and involved in discussions on
trial protocol, CE approach and informed
consent processes.
A pretrial initiative was used to inform
and involve community leaders, and
develop ‘thoughtful, culturally appropriate
messages’ and a consensual community
strategy.
The trial was conducted in partnership








Donor mobilisation of EVD
survivors.
Lab-confirmed EVD patients
Strong focus on donor mobilisation and
role of Survivors Association-motivation to
donate linked to feelings of social
responsibility as survivors.
Issues identified were the stigma and
perceptions of health impacts of donating
blood – a decrease in vital strength and
antibodies, fears of loss of acquired
protection against EVD.
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and enacted in individual studies is clearly complicated
by the extreme challenges faced when conducting health
research in an outbreak setting.
In the following sections, we describe three interre-
lated themes that emerged from our analysis as captur-
ing activities as essential elements that constitute
‘effective’ CE. The three interrelated themes are: (1)
Communication towards building collaborative rela-
tionships; (2) Producing contextual knowledge; and (3)
Learning lessons over time. In addition to interplay be-
tween these themes, there is also variation from the in-
fluence of other elements of the research, including
trial design, human resources, and logistics manage-
ment. This interpretive framework helps us to paint a
picture of the on-the-ground experience, lifting out
nuance and details that might otherwise be lost.
Three CE themes
Theme 1: communication towards building collaborative
relationships The need for accurate and culturally sensi-
tive communication with relevant community stake-
holders about a trial is widely recognised as a critical
preliminary step in the research process [11, 51]. As is
well described in the literature, communication can
serve a range of purposes, from more ‘one-way’ or out-
reach forms of communication to more ‘bi-directional’
or participatory forms-supporting learning and consultation,
for example.
In addition, as for CE as a whole, some purposes
in communicating may have more intrinsic than in-
strumental value, although these may be difficult to
tease apart. An example of an intrinsic value (or
‘good in itself’) would be communication that rea-
lises respect for individuals or communities. Reyn-
olds and Sariola call this intrinsic value the “moral
ideals of scientific research” ([48], p. 257). This is
relevant to the role of listening to, understanding
and responding to a variety of conceptualisations of
disease and health responses to it, which are often
peppered with mistrust, fear and confusion in the
context of an infectious disease outbreak. Communi-
cation then has instrumental value in its ability to
clarify messages, tackle mistrust and generate sup-
port for research, but is also intrinsic in allowing the
lived experiences of stakeholders to be respected,
heard, recognised and integrated into the functioning
of the research.
Unpacking the explicit and implicit aims of commu-
nication methods — particularly in the context of
setting up a new trial, perhaps in a research-naïve
community — can lay the groundwork for continued
communication strategies that are cognisant of their
multiple effects. While broadcasted communication
can be useful in getting information to a large audi-
ence, there are challenges in using this approach to
spread ‘correct’ messages or address rumours and
misinformation if it is not accompanied by multi-
directional, bottom up, interpersonal forms of com-
munication, allowing for sources, justifications and
ontologies of these rumours and misinformation to
emerge and be understood [24, 28].
A helpful interpretation of this general approach to
communication in the context of outbreak research is
given by Kennedy et al. who reframe ‘one-way’ commu-
nication as a more instrumental process, for example
around the ‘dispelling’ of myths and misconceptions
([33], p. 52); and ‘bi-directional’ forms as more intrin-
sic, revealing concerns about health interventions
“stemming from histories of mistrust, rather than sim-
ply being misunderstandings” ([26], p. 8). Instrumental
aims might include increasing recruitment alongside
the dispelling of myths (perhaps also to improve re-
cruitment and retention) but falls short of calls in the
research ethics literature for collaborative partnerships
with community, health provider and policy stake-
holders (at national and local levels) to be a basic
building block of ethical practice [21].
Trial reports make it clear that both one-way (out-
reach) and bi-directional (collaborative) communica-
tion strategies were used in practice. One core and
seemingly obvious reason for paying more attention
to ‘outreach’ is the number and distribution of poten-
tial participants in a trial. The three trials in Sierra
Leone and Liberia that involved large numbers of
healthy volunteers across wide geographic areas
(Ebola ca Suffit, Ebovac Salone, and PREVAIL) paid
more attention to outreach than others, and also built
in bi-directional communication processes. In con-
trast, the trials recruiting volunteers from health
workers (STRIVE) and patient or survivor populations
(JIKI and Ebola Tx) largely reported on interpersonal
communication strategies, at patient/patient group
and policy stakeholder levels, including — in the case
of Ebola Tx — an association of survivors to secure
plasma donors needed for the intervention. Through-
out the accounts in this section, differences in the
‘community’ to be engaged related to the nature of
the trial and was reflected in chosen approaches.
Reflecting the variation in CE approaches with that
of trial design, all teams recognised the importance of
a wide range of communication activities, from out-
reach to bidirectional and interpersonal. For example,
the PREVAIL team described using multiple commu-
nication strategies in different ways to achieve “an
exceptionally high participant retention rate (97%)”,
despite numerous logistical and operational challenges
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([8], p. 50). Throughout the following sections, we
provide examples of different communication activ-
ities and the authors’ reflections on these in terms of
‘effectiveness’ or satisfying aims.
Broad outreach activities
Across the vaccine trials in the core literature, commu-
nication was regularly enacted as forms of outreach or
‘broadcast’, for example through “the local media,
regular press conferences and distribution of flyers,
preparation and airing of jingles and songs on television
and radio, and distribution of text messages” ([33], p.
52). One large communication campaign was the ‘Ebola
Big Idea of the Week’ campaign run by the CDC. It in-
volved approximately 80 radio, television, and print jour-
nalists from Sierra Leone trained by experts to develop
one critical idea every week through culturally sensitive
messaging [6]. For PREVAIL, the strategic plan for ‘so-
cial mobilisation’ included outreach elements of brand-
ing, print and broadcast media communication through
distributing flyers, television, radio and mobile phone
messaging [8]. The aim of these mechanisms was getting
‘facts’ to a wide audience in order to clarify, support and
inform through a largely one-way process, but also to be
part of a wider approach to targeting myths, rumour and
suspicions.
Both of the treatment trials included in the core litera-
ture describe a strong focus on CE with patients and
government health authorities responsible for public
health programming, including service delivery and epi-
demic control measures in the surrounding communi-
ties. The Ebola Tx treatment trial, which involved
transfusion of plasma from EBV donors, had a particu-
larly strong focus on engagement with the EBV Survi-
vors Association, whose cooperation and support
underpinned feasibility of the intervention. Reports from
the JIKI treatment trial in Guinea gave particularly clear
accounts of the challenges and processes for implemen-
tation of the trial at field level. At the first site, a treat-
ment centre in Guéckédou, Perez et al. [47] describe
that CE was understood as “essential to ensuring the ap-
propriate implementation and progression of the trial”
(ibid. p. 7). The challenges faced for CE included the
mistrust of governments and Western humanitarian
agencies, and rumours about EVD. In response, commu-
nication about the trial objectives and implementation
was seen as needing messages that “were adapted to
context, minimised fear, and managed inappropriate ex-
pectations”. A central element of this CE response was
the setting up of a Community Advisory Board (CAB),
comprising local leaders, women’s organisations, youth
groups, religious leaders and village elders (ibid. p. 22).
However, the success of instituting a CAB is difficult to
assess from the research articles. Other closely related
mechanisms to CABs were also used. For example, the
Ebovac Salone research team also set up a Participant
Advisory Group (PAG) in the initial stages of their for-
mative research and their CE strategy involved a wide
range of community stakeholders “from elected and
traditional leaders to individual households” ([25], p. 4).
CE was designed in this respect to link with on-the-
ground organisations and proved valuable for imple-
menting research in an emergency ([44], p. 4). However,
CABs are potentially more reflective of collaborative
partnerships than some other forms of communication
and engagement given the positions of authority that
community members have on them. The PAG may ap-
pear more limited in scope but may provide meaningful
participant advisory in a limited time period of a trial.
Interpersonal and key stakeholder communication
All trials included elements of communication targeting
individuals or specific groupings of potential participants
or ‘influencers’. For the vaccine trials, a study involving
health workers in Sierra Leone used a designated hot
line and information sharing meetings for potential par-
ticipants and the wider health workforce. The PREVAIL
team highlight interpersonal, local, face-to-face commu-
nication as a critical strategy. One such strategy was
employing 25 Liberians living in the main town in the
trial area as ‘participant trackers’ to engage in ongoing
conversations about daily experiences of being in the
trial. The feedback about these ‘participant trackers’ was
that crucial information was collected in determining
the names of participants (in the communities some res-
idents were only known by nicknames), their locations
(using descriptions if there were no street names and
relying on family and friends to have knowledge of their
whereabouts), and the ability to contact them (e.g. a
phone number of a community store) [8]. While Browne
et al. do not comment on the potential for these kinds
of strategies to be intrusive or coercive, they do see ‘ef-
fectiveness’ in the high participant retention, and the
success of strategies such as home visits in avoiding any
overt opposition and dissatisfaction. Another interper-
sonal communication strategy reported was supporting
members of the clinical team (nurses and clinical moni-
tors) to take on communication roles for the trial as part
of their everyday interactions with participants and
others, by reinforcing messages and tackling stigma,
myths and rumours ([8], p. 52).
As a community-based vaccine trial, EBOVAC-Salone
set up a dedicated Community Liaison team that worked
closely alongside trial researchers and a social science
team throughout the study. The main role of the
Community Liaison team was to manage community
messaging and communication, and conditions for par-
ticipation and informed consent, through community
Vanderslott et al. BMC Public Health          (2021) 21:633 Page 9 of 16
and household-level meetings alongside community
leaders (Fayia [29], p. 37).
The literature emphasizes how closely the trial, com-
munity liaison and social science teams worked together,
aiming to inform “research-driven communication strat-
egies” ([24], p. 5). For example, they describe their
process of holding weekly meetings where findings and
feedback could be reported, synthesised and acted upon.
This approach (which overlaps with an aspect of CE dis-
cussed later – incorporating findings and feedback
loops) allows for a communication strategy that is not
only instrumentally effective in managing rumours and
myths and sharing accurate information but creates a
platform for daily experiences to be voiced and incorpo-
rated into the trial’s work. Mooney et al. cite an example
where a rumour that the vaccine trial was bringing Ebola
back to a community was identified by social scientists
and responded to by the community liaison team, who
visited the local marketplace known to be the place
where the rumour had originated. They were then able
to engage with concerned citizens directly, “with the
support of pre-briefed local stakeholders” ([44], p. 439).
The team at STRIVE (a Phase III vaccine trial involving
front line health workers in Sierra Leone) also highlight
communication as important in building community
trust and mitigating rumours and misinformation [11].
The main rationale described for their engagement was
to encourage recruitment, protect participants, and get
buy-in at higher levels of national leadership [12]. The
communication team, with the help of social mobilisation
experts (SMEs) [20], were responsible for ensuring volun-
tary, informed participation [11]. The approach to partici-
pation was based on a tailored social ecology model “to
identify and reach specific spheres that influence a
potential participant’s decision-making” (ibid. S. 41). This
model is a way of showing how an issue can be influenced
at multiple societal levels and was used to reach people
from different spheres with different norms, influences,
perceptions, and support, as well as to foster understand-
ing particular to each sphere (ibid. S. 41). In this trial, in-
formal communication was used instrumentally, where
investing in communication training for all staff was part
of creating a facilitating environment for conversations
seen as at least as constructive as the formal communica-
tion efforts (ibid. S. 46).
Theme 2: producing contextual knowledge –
formative social science research Formative research is
“the process by which researchers or public health prac-
titioners define a community of interest, determine how
to access that community, and describe the attributes of
the community that are relevant to a specific public
health issue” ([13], p. 2). The use of formative research
prior to and for the purpose of informing trial design and
implementation is a core part of CE strategy. The experi-
ences of trials conducted during the West Africa EVD
outbreak demonstrate this. The work done within the
EBOVAC-Salone trial is particularly illustrative of this, as
described by Enria et al. [24] as the “real-time social sci-
ence research”. A locally-recruited social science research
team operated alongside a locally-recruited community
liaison team, and overall clinical research team, with for-
mative social science research playing a crucial role [26].
The social science team included four research assistants
from Kambia District where the trial was located, a data
analyst and a transcriber, with supervision from an LSHT
M social scientist (ibid.). They used a range of traditional
qualitative research methods, including interviews and
ethnographic observation in local social areas and trial
clinics in the three months prior to the trial clinical work.
This ‘stage 1’ research and a second support ‘stage 2’ con-
tinued alongside the clinical part of the trial. A critical as-
pect of the EBOVAC-Salone team’s use of social science
research is that it went past the formative phase and con-
tinued throughout the trial’s CE process.
In terms of the types of social science methods
employed, for the Ebola treatment trial with convalescent
plasma, an anthropological pre-trial assessment was car-
ried out to better understand the context, acceptability of
EVD therapies, stakeholders expectations ([18], p. 648) as
well as volunteer motivations, concerns, and their under-
lying influences [49]. It is unclear who conducted the as-
sessment or whether results were published as a separate
set of findings; however, the findings demonstrated the
importance of stakeholder communication “to under-
stand and follow up what people thought, felt, perceived,
and how they acted during the EVD outbreak and conse-
quential health control activities” ([18], p. 648). This led
to discussions about how stakeholders, particularly mem-
bers of the survivors association that was set up, could be
involved in the study. Another example of a reflection of
social science methods is the systematic literature review
by Johnson and Vindrola-Padros, “Rapid qualitative re-
search methods during complex health emergencies” [32]
and subsequent rapid review methodology articles relat-
ing to COVID-19 pandemic research [54, 55]. Rapid
qualitative methods were effective in understanding com-
munity resilience for public health emergencies and plan-
ning CE based on this.
Other social science research concentrated on specific
aspects of community perceptions and behaviours that
affected the public health response. This included moti-
vations for volunteering in research studies (Fayia [29]);
the reception to the “bushmeat ban” and public health
messaging about the risks of consuming bushmeat [7];
to wider questions about the connection to understand-
ings of citizenship and belonging through encounters
with biomedicine [23].
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A number of questions arise in the use of formative
research to understand context during epidemics for fu-
ture consideration. Can anthropological research be
done in such a short period, especially in a research-
naïve area? Who are the anthropologists doing this re-
search? What if the results of their research suggest an
unsuitable setting for clinical research? Could the entire
trial be relocated given the extreme logistical and time
constraints? In other words, what are the specific inten-
tions and aims of the formative research - to prime the
setting or to ask open-ended questions about the ethical,
social, cultural and historical feasibility of conducting tri-
als in the setting? These studies have shown that these
broader questions have largely gone unanswered and will
need to be considered for future formative research in
outbreaks.
Theme 3: learning lessons over time – incorporating
findings, creating feedback loops and building a
sustaining legacy To learn lessons means relying on
collaborative partnerships so that the various stakeholder
ideas and recommendations are taken seriously and built
into plans going forwards. The feedback of this informa-
tion often takes place outside formal structures such as
CABs. Knowing and understanding whose feedback is
getting incorporated and why is an important step in
mapping out the effectiveness of CE strategy. Browne,
et al. [8] note how PREVAIL nurses responded to partic-
ipants’ experiences of stigma by reiterating messages
relayed by the Social Mobilisation Experts (SMEs) as
part of their broader strategy. Community health
workers (CHWs) are also highlighted by Miller et al.
[40] as playing an important role during the EVD out-
break and remained active in their communities after.
This multiplicity of roles and the use of different stake-
holder channels for reinforcement of messaging is an
on-the-ground reality difficult to capture in descriptions
of formal communication structures and strategies.
The PREVAIL trial’s fourth social mobilisation strategy
pillar was monitoring and evaluating mobilisation activ-
ities, including “joint review mechanisms that incorpo-
rated community leaders, diverse community groups,
and government partners to ensure output, impact and
challenges of the social mobilisation campaign were
identified and changes instituted address existing gaps”
([33], p. 53). The trial design was adapted as a result of
incorporating feedback. Study protocols are fairly inflex-
ible once finalised, but in cases where it is possible, get-
ting feedback on the study design before it is finalised
(usually through formative research) from local stake-
holders and community members is essential for includ-
ing communities in the design of research.
The EBOVAC-Salone recruitment strategy was strongly
informed by clinical expertise, conversations with local
staff and insights from anthropological research, and thus
shaped according to both clinical standards and local per-
ceptions of what a “fair” and “representative” selection
process should be: “Given assumptions that access to re-
sources is assumed to be based on “connectocracy”, there
was the potential that, given the limited number of partici-
pants required, people could have assumed that the “big
ones” were picking themselves and those they knew” ([24],
p. 6). Sierra Leone’s history of conflict opened the poten-
tial for “participant recruitment to be likened to forced
conscription” and added sensitivities for the trial recruit-
ment process (ibid.). Table 3 below outlines the stages of
feedback loops.
Compensation and plausible benefit was provided, such
as the EBOVAC-Salone trial offering participants com-
pensation for transportation to the clinic but other trials
at different locations in the country at that time offered
more money and sometimes a mobile phone ([44], p.
439). Some saw the provisions of incentives as a worrying
commodification tantamount to “exchanging blood, one’s
life essence, for money” and generous financial compen-
sation was not necessary to stimulate participation in the
trial in Kambia (ibid.). Still, the Liberian trial team
assigned dollar amounts appropriate for the PREVAIL
trial setting with compensation for inconvenience, which
may have contributed to retention: A baseline visit was
$40.00, follow-up blood draw was $20.00, and close out
visit was $150.00 ([8], p. 53). Building future infrastruc-
ture was another way for CE to have both intrinsic
and instrumental value. For example, the formation
of the ‘Global Emerging Pathogens Consortium’
(GET), a civil society group comprised of African
academics, scientists, clinician, and civil society as a crisis
response network, is an example of an enduring legacy
for CE [1].
We have summarised our findings through three
themes: (1) Communication towards building collabora-
tive relationships; (2) Producing contextual knowledge;
and (3) Learning lessons over time. See Table 4 below
for the full list of all papers in this review, divided speci-
fically by the themes and also whether they were general
trial or trial-related papers.
Across our review of 59 papers, the core material related
exclusively to health research trials during the 2014–2016
West Africa Ebola outbreak in Liberia, Sierra Leone,
and Guinea. In addition, even though we included
studies from 1990, the majority were from 2015 onward.
In some cases, reports of CE practices were limited to a
few paragraphs in articles primarily focused on other
elements such as study design and reporting results
[18, 31, 33]. However, some trial groups authored
full-length publications in which community engage-
ment aspects were amongst the main foci of the
paper [11, 44].
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Discussion: Key elements for ‘effectiveness’ in CE We
have reviewed the literature on CE for health research
for infectious disease outbreaks in Sub-Saharan Africa.
While there is a large volume of literature documenting
CE activities in infectious disease research settings gen-
erally, there are few accounts of effectiveness dimensions
of CE. Our review proposes the consideration of three
themes by researchers to facilitate the effectiveness of
their CE initiatives. After identifying the high-level prin-
ciples and benchmark documents we looked to the three
core areas of literature of ethics, public health response,
and outbreak research; then we assessed how these
translated to on-the-ground CE.
In the previous sections, we have described three
themes that emerged from our analysis as particularly
important in informing the effectiveness of CE planned
and implemented during health research in outbreaks.
Clearly, research design has a crucial influence on the
nature of CE planned, and in particular, the extent to
which geographically defined communities might be im-
plicated by the research activity.
We have made a first core argument that communica-
tion approaches should be multifaceted and tailored to
context, but include elements that build collaborative re-
lationships between partners. A helpful interpretation of
this general approach to communication in the context
of outbreak research is given by Kennedy [33] who
reframes ‘one-way’ communication as a more reactive
process, for example around the dispelling of myths and
misconceptions ([33], p. 52), and ‘bi-directional’ forms as
more exploratory, revealing and taking seriously the con-
cerns about health interventions held by communities
where the research is situated [26].
The move from ‘one-way’ forms of communication to-
wards bi-directional communication or even collabora-
tive relationships implies a shift from less to more
Table 3 Stages of feedback loops. Based on article by [24]: p. 4
1. CE plans feedback Social science team feedback to study team on CE plans based on socio-cultural research, local community dynamics
and perceptions of the vaccine trial.
2. Meetings to discuss issues Brought up issues encountered by the trial team/ community liaison staff requiring further research by social science
team (e.g. design of the recruitment strategies).
3. Reporting rumours/
concerns
The social science team reported on rumours or concerns and communicated these to the community liaison team
anonymously (not to breach confidentiality and to maintain independence of research).
4. Response by community
liaison staff
Following feedback, the community liaison staff brainstormed strategies to respond to concerns and rumours.
Strategies depended on specific issues raised, but usually involved different creative avenues for discussion with
community and reviewing messaging to actively engage, as well as determining who was the best person in the
team to respond and through which channel.
Table 4 Literature divided by trials and three themes
Ebola trials and trial-related 1. Communication Towards
Building Collaborative
Relationships
2. Producing contextual knowledge:
Formative social science research
3. Learning lessons over time:
Incorporating findings, creating
feedback loops and building a
sustaining legacy
Abramowitz et al. 2018 [2]
Alirol et al. 2017 [3]
Caleo et al. 2018 [10]
Coltart et al. 2017 [15]
Dean et al. 2016 [17]
Emanuel et al. 2004
Folayan et al. 2015 [30]
Keusch et al, 2017 [34]
Marsh et al, 2008 [38]
Marchant & Lees, 2019 [37]
Mehand et al. 2018 [39]
Mills et al. 2005 [41]
Olu et al. 2016 [45]
Pedi et al. 2017 [46]
Slevin et al. 2008 [50]
Tindana, 2007 [52]
UNAIDS, AVAC. 2011 [53]
Wellcome Trust and CIDRAP, 2015 [14]
WHO, 2017 [59]
WHO, 2016 [57]
Wilkinson et al. 2017 [58]
Bedrosian et al. 2016 [6]
Browne et al. 2018 [8]
Callis et al. 2018 [11]
Carter et al. 2018 [12]
Ebola ça suffit consortium 2015 [20]
Emanuel et al. 2005 [21]
Enria et al. 2016 [24]
Enria et al. 2016a [25]
Enria et al. 2016b [26]
Fairhead 2016 [28]
Perez et al. 2017 [47]
Fayia Tengbeh et al. 2018 Fayia [29]
Kennedy et al. 2016 [33]
Mooney et al. 2018 [44]
Reynolds & Sariola 2018 [48]
Spengler et al. 2016 [51]
CDC. 2013 [13]
Bonwitt et al. 2018 [7]
Delamou et al. 2016 [18]
Enria and Lees 2018 [23]
Enria et al. 2016 [24]
Fayia Tengbeh et al. 2018 Fayia [29]
Ronse et al. 2018 [49]
Johnson & Vinndrola-Padros, 2017 [32]
Abayomi et al. 2016 [1]
Browne, et al. 2018 [8]
Callis et al. 2018 [11]
Delamou et al. 2016 [18]
Enria et al. 2016 [24]
Henao-Restrepo et al. 2016 [31]
Kennedy et al. 2016 [33]
Miller et al. 2018 [40]
Mooney et al. 2018 [44]
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participatory forms of CE, as has been commented on
elsewhere in this article. Unpacking the different impli-
cations of these two (sometimes conflicting) approaches
to CE is important for clarifying and achieving its aims.
Whether CE is undertaken for exploratory or reactive
reasons, the question of who benefits is still relevant, as
is that of how fairly the benefits are distributed. Reluc-
tance to overburden the public health response team
features strongly among researchers and practitioners
designing and implementing CE for research in out-
breaks, noting that CE for a public health response and
in support of research may rely on the same teams.
Overcoming impediments of mistrust, conflicting per-
ceptions, and misunderstandings of the relationship be-
tween research and response are also acknowledged in
the literature on CE for research in outbreaks.
We have made a second argument that social science
research-formative and ongoing-is a critical component
in guiding the shape and content of CE during an out-
break and ensuring that the collaborative relationships
researchers aim to build are well-founded, meaningful
and durable. Our third argument then stems from the
first two, to highlight the importance of a commitment
to learning lessons from on-going experiences during an
outbreak, so that research teams can flexibly adapt and
sustain the collaborative relationships on which the re-
search enterprise depends. We extend this third argu-
ment further, to agree with the authors of the WHO
GPP-EP guidelines that in view of long-standing struc-
tural inequities that characterise settings in which out-
breaks are likely to arise, there should be a long-term
commitment to supporting a sustainable legacy for
communities.
Our review suggests that good practice in CE in the
context of outbreak research (and potentially for re-
search in general) is underpinned by bi-directional com-
munication, the careful longitudinal incorporation of
social science research into planning, and ensuring that
structures are in place to support meaningful feedback
and adaptation of research practice on the ground. This
includes efforts to ensure that CE has an enduring legacy
from research, for the benefit of a widely defined com-
munity. Through this scoping review we have found
that, while CE research literature documents the activ-
ities of CE conducted in the context of clinical research
during disease outbreaks, the next step of deriving the
essential elements of meaningful and effective engage-
ment has not been taken and is what makes this scoping
review novel. Going forward, the additional work needed
in order to further knowledge in assessments of CE will
be to consider broader implications of CE on an aggre-
gate level, taking into consideration the kinds of research
– largely qualitative – that may answer some of these
questions.
However, we do acknowledge the following limita-
tions. First, we made the decision to limit our research
to Sub-Saharan Africa. A comparative global review may
prove useful, particularly with the Americas and Asian
regions where different outbreaks have taken place re-
cently (Dengue, Zika etc.), inviting varied CE responses.
In light of the COVID-19 pandemic, a truly global re-
view for CE responses would also be very valuable.
Second, our review was largely confined to the English
language, and only reviewed one paper in French.
Further language searches would add to the body of
knowledge.
Conclusion
We have presented our findings from a synthesis of
three key themes arising from descriptions of CE strat-
egies and their effectiveness, as essential elements of CE
activities in infectious diseases studies: (1) Communica-
tion towards building collaborative relationships; (2)
Producing contextual knowledge; and (3) Learning
lessons over time. Researchers and their partners imple-
menting CE programs for health research in epidemics
can use these themes to guide improving practice.
Throughout the process of conducting this review
(and also confirmed at the ALERRT 2019 Community
Engagement Workshop in Senegal), it has become ap-
parent that strengthening CE is both an art and a
process, a philosophy and a science. Achieving both the
instrumental aims (effectiveness, strengthening, quality,
and impact) and intrinsic aims (respect, recognition, and
equality) of CE requires a deliberative effort through the
nexus of relationships, knowledge, and lesson-learning
for better listening to and speaking with communities
affected by outbreaks of infectious diseases. The import-
ance of documenting and sharing lessons learnt to
improve CE practice remains paramount as current
epidemics continue.
We set out to characterise the nature and effectiveness
of CE activities in infectious disease research settings in
Sub-Saharan Africa. Given the nature of the wider
literature on community engagement in research, our
findings act to underline their interrelatedness of these
themes and their core role in supporting ‘effectiveness’
across the literature reviewed on CE during the EBV epi-
demic. There is value in concentrating on these areas in
planning CE in similar situations in future. As there
were relatively few in-depth accounts of CE from our lit-
erature review, documentation and accounts of CE used
in health research should be prioritised going forward,
thus contributing to more thorough trial reporting in
the future. A further lesson is the need for more re-
search and analysis on what constitutes effectiveness in
CE in research, and greater transparency in reporting
Vanderslott et al. BMC Public Health          (2021) 21:633 Page 13 of 16
around the processes and impacts of CE. A deeper un-
derstanding through more comprehensive reporting of
the mechanisms of CE would provide stakeholders with
a benchmark for assessing the ethical principles around
CE and offer a tangible, on-the-ground opportunity to
enact them.
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